Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MacroGenics diabetes drug given orphan status
MacroGenics is planning to initiate a phase II/3 trial to study MGA031 in patients with recent-onset type 1 diabetes in the fourth quarter of 2006. “In previous clinical
MacroGenics is planning to initiate a phase II/3 trial to study MGA031 in patients with recent-onset type 1 diabetes in the fourth quarter of 2006. “In previous clinical
The agreement will be specifically with the National Institute of Allergy and Infectious Diseases (NIAID), a department of the National Institutes of Health. The collaborative research will combine
Ceplene is to be administered in conjunction with interleukin-2 (IL-2), for the maintenance of first remission in patients with acute myeloid leukemia (AML). The European Commission has previously
The company plans to resume the clinical trials that were underway at the time the clinical hold was put into effect. The FDA put the trials on hold
PowderMed has developed technology to deliver DNA directly to the cells of the body’s immune system and is advancing a promising pipeline of proprietary vaccine candidates for influenza
SDSU Heart Institute researchers found that by inhibiting two proteins, microsomal triglyceride transfer protein (MTP) and liver fatty acid-binding protein (L-FABP), liver production of lipoproteins can be blocked
In the study, 60% of hypertensive children had a condition called sleep disordered breathing (SDB). SDB is characterized by short periods of upper airway obstructions that are complete
Although the information was already included on the label, the company has made the decision to add the black box to make the warning more visible to patients
The approval of FluLaval is an attempt to increase the influenza vaccine supply in the US. The approval of FluLaval follows the introduction of GSK's Fluarix prior to
The study from McGill University Health Centre identified the gene most often responsible for leber congenital amaurosis (LCA), the most common form of congenital blindness, which is currently